SCIESCOPUSQ1
Nucleic Acid Therapeutics
MARY ANN LIEBERT, INC, United States
Nucleic Acid Therapeutics은(는) MARY ANN LIEBERT, INC(United States)에서 발행하는 학술지입니다. 식별자: ISSN 2159-3337, eISSN 2159-3345. SCIE, SCOPUS에 등재되어 있습니다. 지표: JIF 4.7, CiteScore 8.2, SJR 1.499, SNIP 0.98. 주제 분야: BIOCHEMISTRY & MOLECULAR BIOLOGY, CHEMISTRY, MEDICINAL, MEDICINE. tlooto에서 이 학술지의 논문 672편을 볼 수 있습니다.
CiteScore
8.20
Scopus 인용 지표
SJR
1.499
SCImago 저널 순위
SNIP
0.98
분야 보정 인용 영향력
Percentage rank
-
JIF 백분위 순위
저널 기본 정보
- ISSN
- 2159-3337
- eISSN
- 2159-3345
- 약어
- NUCLEIC ACID THER
- 출판사
- MARY ANN LIEBERT, INC
- 국가
- United States
Web of Science 카테고리
SCIEBIOCHEMISTRY & MOLECULAR BIOLOGY, CHEMISTRY, MEDICINAL, MEDICINE, RESEARCH & EXPERIMENTAL
Scopus ASJC 카테고리
1303 Biochemistry1311 Genetics1312 Molecular Biology1313 Molecular Medicine3002 Drug Discovery
키워드
Biochemistry & Molecular Biology | Chemistry, Medicinal | Medicine, Research & Experimental
이 학술지의 논문
최근 논문
- The Approval of Redemplo for Familial Chylomicronemia Syndrome and the Many Flavors of GalNAc-Oligonucleotides.
2026
- Conjugated Antisense Oligonucleotides for Skipping of Duchenne Muscular Dystrophy Exon 53: A Cautionary Study
2026
- Embryo–Fetal Development and Maternal–Fetal Exposure of the Von Willebrand Factor Binding Aptamer Rondaptivon Pegol (BT200) in Rabbits
2026
- Evaluation of Antisense Oligonucleotide-Associated Neuronal Lysosomal Changes
2026
- Aptamers: Current Applications in Leukemia Diagnostics and Therapeutics.
2026
많이 인용된 논문
- GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
2018 · 인용 593회
- Phosphorothioates, Essential Components of Therapeutic Oligonucleotides
2014 · 인용 579회
- Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
2018 · 인용 483회
- Molecular Mechanisms of Antisense Oligonucleotides
2017 · 인용 323회
- FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga
2017 · 인용 315회